Ibuprofen Tablets recall — Class II (D-0647-2024) · pharmaranks
Class IIOngoing
Ibuprofen Tablets recall
FDA recall D-0647-2024 · initiated Aug 8, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Failed Impurities/Degradation Specifications - at 18-month Stability testing
Details
Product
Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.
Recalling company
Preferred Pharmaceuticals, Inc.
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
CA and NV
Initiated
Aug 8, 2024
FDA report date
Sep 4, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.